Third Wave seeks approval of Cystic Fibrosis test
Third Wave Technologies has applied for Food and Drug Administration approval of a new molecular test to detect Cystic Fibrosis, a hereditary disease that affects 30,000 Americans. The company filed a 510(k), a type of application that helps companies get their products on the U.S....